Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Innovate (VATE) over the last 15 years, with Q4 2024 value amounting to $100000.0.

  • Innovate's Asset Writedowns and Impairment fell 9166.67% to $100000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year increase of 555.56%. This contributed to the annual value of $100000.0 for FY2024, which is 9444.44% down from last year.
  • Per Innovate's latest filing, its Asset Writedowns and Impairment stood at $100000.0 for Q4 2024, which was down 9166.67% from $1.2 million recorded in Q4 2023.
  • Over the past 5 years, Innovate's Asset Writedowns and Impairment peaked at $11.1 million during Q3 2020, and registered a low of $100000.0 during Q1 2020.
  • For the 5-year period, Innovate's Asset Writedowns and Impairment averaged around $1.4 million, with its median value being $100000.0 (2020).
  • Data for Innovate's Asset Writedowns and Impairment shows a peak YoY increase of 200000.0% (in 2021) and a maximum YoY decrease of 9600.0% (in 2021) over the last 5 years.
  • Innovate's Asset Writedowns and Impairment (Quarter) stood at $2.5 million in 2020, then tumbled by 96.0% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then soared by 1100.0% to $1.2 million in 2023, then crashed by 91.67% to $100000.0 in 2024.
  • Its last three reported values are $100000.0 in Q4 2024, $1.2 million for Q4 2023, and $500000.0 during Q3 2023.